- Choroidal neovascularization removal before stem cell transplantation may improve safety and effectiveness.
- Close adhesion of the choroidal neovascularization to the underlying tissue is a significant surgical risk factor.
- Group 1 patients showed better visual outcomes compared to Group 2 patients.
- Study limitations include a small sample size and the need for long-term follow-up.
- CNV recurrence occurred in 1 patient from group 2 at 9 months, requiring additional antivascular endothelial growth factor therapy.
- Persistent fundus inflammation and postoperative complications were observed in group 2 patients.
Source: Stem Cell Reports
